HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wan Sung Choi Selected Research

Betaxolol (Kerlon)

10/2003Betaxolol attenuates retinal ischemia/reperfusion damage in the rat.
3/2003Change in endothelial nitric oxide synthase in the rat retina following transient ischemia.
9/2002Nitric oxide synthase expression in the transient ischemic rat retina: neuroprotection of betaxolol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wan Sung Choi Research Topics

Disease

14Neoplasms (Cancer)
01/2019 - 07/2003
11Seizures (Absence Seizure)
04/2013 - 02/2003
7Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2021 - 07/2016
6Ischemia
10/2008 - 09/2002
5Inflammation (Inflammations)
10/2017 - 06/2003
5Glioma (Gliomas)
11/2015 - 03/2011
4Ganglion Cysts (Ganglion)
10/2017 - 06/2003
4Diabetic Retinopathy (Retinopathy, Diabetic)
10/2017 - 12/2002
4Hypoxia (Hypoxemia)
02/2014 - 10/2002
4Drug Resistant Epilepsy
11/2008 - 10/2004
3Carcinogenesis
01/2018 - 02/2014
2Neuroinflammatory Diseases
10/2017 - 12/2011
2Diabetes Mellitus
10/2017 - 06/2003
2Lung Neoplasms (Lung Cancer)
01/2017 - 05/2007
2Fibrosis (Cirrhosis)
09/2015 - 05/2006
2Obesity
09/2015 - 06/2012
2Reperfusion Injury
06/2014 - 10/2003
2Neuroblastoma
08/2013 - 09/2006
2Status Epilepticus (Complex Partial Status Epilepticus)
06/2012 - 11/2010
2Neurodegenerative Diseases (Neurodegenerative Disease)
04/2006 - 10/2003
2Brain Injuries (Brain Injury)
10/2005 - 10/2003
1Type 2 Diabetes Mellitus (MODY)
01/2019
1Hyperglycemia
10/2017
1Body Weight (Weight, Body)
10/2017
1Neoplasm Metastasis (Metastasis)
07/2017
1Cognitive Dysfunction
04/2016
1Weight Gain
09/2015
1Insulin Resistance
09/2015
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2015
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2015
1Glioblastoma (Glioblastoma Multiforme)
01/2015
1Diabetes Complications
05/2014

Drug/Important Bio-Agent (IBA)

10Kainic Acid (Kainate)IBA
04/2013 - 02/2003
6Proteins (Proteins, Gene)FDA Link
03/2021 - 07/2003
5ClusterinIBA
01/2018 - 06/2003
5Retinaldehyde (Retinal)IBA
10/2017 - 03/2003
4Small Interfering RNA (siRNA)IBA
11/2020 - 03/2011
4Streptozocin (Streptozotocin)FDA Link
10/2017 - 06/2003
4Ethanol (Ethyl Alcohol)IBA
04/2016 - 05/2005
3Oncogene Proteins (Oncogene Protein)IBA
11/2020 - 07/2016
3Pharmaceutical PreparationsIBA
01/2019 - 05/2007
3Glucose (Dextrose)FDA LinkGeneric
01/2019 - 09/2015
3TransferasesIBA
10/2017 - 07/2017
3ResveratrolIBA
11/2015 - 12/2011
3NF-kappa B (NF-kB)IBA
09/2015 - 07/2007
3Tacrolimus (Prograf)FDA LinkGeneric
06/2014 - 10/2008
3Glutamic Acid (Glutamate)FDA Link
04/2013 - 03/2006
3Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2012 - 10/2002
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2011 - 10/2002
3Messenger RNA (mRNA)IBA
12/2011 - 07/2003
3Anticonvulsants (Antiepileptic Drugs)IBA
12/2006 - 10/2004
3Betaxolol (Kerlon)FDA LinkGeneric
10/2003 - 09/2002
2UbiquitinIBA
03/2021 - 11/2020
2Complementary DNA (cDNA)IBA
03/2021 - 12/2002
2Metformin (Glucophage)FDA LinkGeneric
01/2019 - 10/2017
2AcetylglucosamineIBA
01/2019 - 01/2017
2UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferaseIBA
01/2018 - 07/2016
2NFATC Transcription FactorsIBA
10/2017 - 05/2014
2TristetraprolinIBA
11/2015 - 01/2015
2thiamine triphosphorate (TTP)IBA
11/2015 - 01/2015
2Plasminogen Activators (Plasminogen Activator)IBA
01/2015 - 12/2011
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2015 - 12/2011
2CalcineurinIBA
06/2014 - 10/2008
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2013 - 03/2011
2Caspase 3 (Caspase-3)IBA
05/2012 - 11/2010
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
05/2012 - 11/2010
2deoxyuridine triphosphateIBA
05/2012 - 11/2010
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2011 - 05/2007
2Glycoproteins (Glycoprotein)IBA
05/2011 - 03/2011
2Cisplatin (Platino)FDA LinkGeneric
03/2011 - 05/2007
2CaspasesIBA
03/2011 - 06/2009
2Neuroprotective AgentsIBA
10/2009 - 10/2003
2Nitric Oxide Synthase (NO Synthase)IBA
02/2006 - 10/2002
1RNA (Ribonucleic Acid)IBA
03/2021
1ThioredoxinsIBA
03/2021
1GelsolinIBA
11/2020
1O-GlcNAc transferaseIBA
01/2019
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2019
1QuercetinIBA
12/2018
1Protein Kinases (Protein Kinase)IBA
12/2018
1Adenosine Monophosphate (AMP)IBA
12/2018
1FlavonoidsIBA
12/2018
1Liver X ReceptorsIBA
01/2018
1SterolsIBA
01/2018
1Carrier Proteins (Binding Protein)IBA
01/2018
1CXC ChemokinesIBA
07/2017
1Sirtuin 1IBA
09/2015
1Neurotransmitter Agents (Neurotransmitter)IBA
03/2015
1Urokinase Plasminogen Activator ReceptorsIBA
01/2015
1Protein Kinase CIBA
05/2014
1Aldehyde Reductase (Aldose Reductase)IBA
05/2014
1Protein Isoforms (Isoforms)IBA
02/2014
1LuciferasesIBA
02/2014
1ChromatinIBA
02/2014
1HydrolasesIBA
10/2013
1AmidesIBA
10/2013
1Carbon Nanotubes (Carbon Nanotube)IBA
10/2013
1Y 27632IBA
04/2013

Therapy/Procedure

8Ketogenic Diet
12/2011 - 02/2003
1Intraperitoneal Injections
10/2017